Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-22T19:23:22.039Z Has data issue: false hasContentIssue false
  • English
  • Français

Apolipoprotein ϵ4 status is associated with behavioral symptoms in nursing home residents with dementia

Published online by Cambridge University Press:  01 August 2009

Diana Lynn Woods ,
Brittany Bushnell ,
Haesook Kim ,
Daniel Geschwind  and
Jeffrey Cummings
Diana Lynn Woods*
Affiliation:
School of Nursing, University of California, Los Angeles, U.S.A.
Brittany Bushnell
Affiliation:
School of Nursing, University of California, Los Angeles, U.S.A.
Haesook Kim
Affiliation:
School of Nursing, University of California, Los Angeles, U.S.A.
Daniel Geschwind
Affiliation:
Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, U.S.A.
Jeffrey Cummings
Affiliation:
Department of Neurology, David Geffen School of Medicine, and UCLA Alzheimer's Disease Research Center, University of California, Los Angeles, U.S.A.
*
Correspondence should be addressed to: Diana Lynn Woods, Assistant Professor, University of California, Los Angeles, School of Nursing, 700 Tiverton Avenue, Box 956919, Los Angeles, CA 90095-6919, U.S.A. Phone: + 1 310 206-5457; Fax: +1 310 206-3241. Email: [email protected].
Get access

Abstract

Background: While the relationship of apolipoprotein E (APOE) to behavioral symptoms of dementia (BSD) has been studied in community-dwelling persons with AD, it has received limited attention within the nursing home (NH) population. The aim of this study was to examine the association between APOE genotype and BSD in NH residents using direct observation.

Methods: Thirty-six participants, aged 71–102 years, were compared using a non-randomized two-group design with continuous measures. APOE genotype was obtained by buccal swab. BSD, including restlessness, escape restraint, tapping and banging, searching and wandering, pacing and walking, and vocalization, were measured using the Modified Agitated Behavior Rating Scale. Participants were observed every 20 minutes for 12 hours per day for five days. Each participant's mean behavior scores were compared according to the presence or absence of the APOE ϵ4 allele.

Results: Resident characteristics included a mean MMSE of 10.44 indicating moderate to severe dementia and a mean of 3.44 medical co-morbidities. Fifty-six percent of the participants had one ϵ4 allele. A significant difference was found between APOE ϵ4+/4− and mean behavioral scores (F1,31 = 4.40, p = 0.04). Restlessness was significantly inversely correlated with MMSE (r = −0.367, p = 0.03), but not APOE genotype. There was no significant correlation between proxy reporting and direct observation (r = 0.257, p = 0.13).

Conclusion: Findings indicate that the presence of the APOE ϵ4+ genotype increases the risk for BSD in NH residents with dementia. Direct observation proved a more accurate estimate of BSD than proxy report.

Keywords

agitationbehavioral symptoms in dementiaAPOE ϵ4 allelelong-term care
Type
Research Article
Information
International Psychogeriatrics , Volume 21 , Issue 4 , August 2009 , pp. 722 - 728
Copyright
Copyright © International Psychogeriatric Association 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington, DC: American Psychiatric Association.Google Scholar
Beck, C. et al. (1998). Correlates of disruptive behavior in severely cognitively impaired nursing home residents. Gerontologist, 38, 189–198.Google Scholar
Bedford, S., Melzer, D. and Guralnik, J. (2001). Problem behavior in the last year of life: prevalence, risks, and care receipt in older Americans. Journal of the American Geriatrics Society, 49, 590–595.CrossRefGoogle ScholarPubMed
Brooke, V. (1989). Nursing home life: how elders adjust. Geriatric Nursing, 10, 66–68.Google Scholar
Cariaga, J., Burgio, L., Flynn, W. and Martin, D. (1991). A controlled study of disruptive vocalizations among geriatric residents in nursing homes. Journal of the American Geriatrics Society, 39, 501–507.CrossRefGoogle ScholarPubMed
Caselli, R. J., Reiman, E. M., Hentz, J. G., Osborne, D. and Alexander, G. E. (2004). A distinctive interaction between chronic anxiety and problem solving in asymptomatic APOE e4 homozygotes. Journal of Neuropsychiatry and Clinical Neurosciences, 16, 320–329.CrossRefGoogle ScholarPubMed
Cohen-Mansfield, J. (1986). Agitated behaviors in the Elderly: II. Preliminary results in the cognitively deteriorated. Journal of the American Geriatrics Society, 34, 722–727.CrossRefGoogle ScholarPubMed
Cohen-Mansfield, J. and Libin, A. (2004). Assessment of agitation in elderly patients with dementia: correlations between informant rating and direct observation. International Journal of Geriatric Psychiatry, 19, 881–891.Google Scholar
Cohen-Mansfield, J. and Werner, P. (1998). Predictors of aggressive behaviors: a longitudinal study in senior day care centers. Journal of Gerontology, B: Psychological Science Social Science, 53, 300–310.Google Scholar
Corder, E. H. et al. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921–923.CrossRefGoogle ScholarPubMed
Craig, D., Hart, D. J., McCool, K., McIlroy, S. P. and Passmore, A. P. (2004). Apolipoprotein E e4 allele influences aggressive behavior in Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 75, 1327–1330.CrossRefGoogle ScholarPubMed
Davignon, J., Cohn, J. S., Mabile, L. and Bernier, L. (1999). Apolipoprotein E and atherosclerosis: insight from animal and human studies. Clinica Chimica Acta, 286, 115–143.Google Scholar
Eichner, J., Dunn, S., Perveen, G., Thompson, D., Stewart, K. and Stroehla, B. (2002). Apolipoprotein E polymorphism and cardiovascular disease: a human genome epidemiology review. American Journal of Epidemiology, 155, 487–495.CrossRefGoogle Scholar
Evans, D. A. et al. (1997). Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older persons. JAMA, 277, 822–824.CrossRefGoogle Scholar
Finkel, S. I., Lyons, J. and Anderson, R. L. (1993). A brief agitation rating scale (BARS) for nursing home elderly. Journal of the American Geriatrics Society, 41, 50–52.Google Scholar
Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). Mini mental state: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.CrossRefGoogle Scholar
Gabryelewicz, T. et al. (2002). Behavioural pathology in Alzheimer's disease with special reference to apolipoprotein E genotype. Dementia and Geriatric Cognitive Disorders, 14, 208–212.Google Scholar
Haan, M. N., Shemanski, L., Jagust, W. J., Manolio, T. A. and Kuller, L. (1999). The role of APOE ϵ4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA, 282, 40–46.Google Scholar
Katz, S. and Akpom, C. A. (1976). Index of ADL. Medical Care, 14, 116–118.Google Scholar
Kolovou, G. and Anagnostopoulou, K. (2007). Apolipoprotein E polymorphism, age and coronary heart disease. Ageing Research Review, 6, 94–108.Google Scholar
Kozauer, N. A., Mielke, M. M., Chan, G. K., Rebok, G. W. and Lyketsos, C. G. (2008). Apolipoprotein E genotype and lifetime cognitive decline. International Psychogeriatrics, 20, 109–123.Google Scholar
Mahley, R. W. and Rall, S. C. Jr. (1999). Is epsilon4 the ancestral human apoE allele? Neurobiology of Aging, 20, 429–430.Google Scholar
Raber, J. (2007). Role of apolipoprotein E in anxiety. Neural Plasticity, 2007, doi: 10.1155/2007/91236CrossRefGoogle Scholar
Robertson, J., Curley, J., Kaye, J., Quinn, J., Pfankuch, T. and Raber, J. (2005). apoE isoforms and measures of anxiety in probable AD patients and Apoe-/- mice. Neurobiology of Aging, 26, 637–643.Google Scholar
Scarmeas, N. et al. (2002). Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease. Neurology, 58, 1182–1188.CrossRefGoogle ScholarPubMed
Shrout, P. E. and Fleiss, J. L. (1979). Intraclass correlations: uses in assessing rater reliability. Psychological Bulletin, 86, 420–428.CrossRefGoogle ScholarPubMed
van der Flier, W. M. et al. (2007). Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer disease. Dementia and Geriatric Cognitive Disorder, 23, 42–46.Google Scholar
Vertesi, A. et al. (2001). Standardized Mini-mental State Examination: use and interpretation. Canadian Family Physician, 47, 2018–2023.Google ScholarPubMed
Woods, D. L. and Dimond, M. (2002). The effect of therapeutic touch on agitated behavior and cortisol in persons with Alzheimer's disease. Biological Research for Nursing, 4, 104–114.CrossRefGoogle ScholarPubMed
Woods, D. L., Kovach, C. R., Raff, H., Joosse, L., Basmadjian, A. and Hegadoren, K. M. (2008). Using saliva to measure endogenous cortisol in nursing home residents with advanced dementia. Research in Nursing and Health, 31, 283–294.Google Scholar